Telix制药公司将在2026年1月12日J.P.摩根保健会议上介绍其药物管道。 Telix Pharmaceuticals to present its drug pipeline at J.P. Morgan Healthcare Conference on January 12, 2026.

Telix制药公司将在2026年1月12日J.P.摩根保健会议上介绍其输油管和商业组合,并提供30天的网上直播。 Telix Pharmaceuticals will present its pipeline and commercial portfolio at the J.P. Morgan Healthcare Conference on January 12, 2026, with a live webcast available for 30 days. 该公司总部设在墨尔本,在ASX和Nasdaq上市,在全球开展业务,并将分享其肿瘤病和罕见疾病的放射药剂的最新消息。 The company, headquartered in Melbourne and listed on ASX and Nasdaq, operates globally and will share updates on its radiopharmaceuticals for oncology and rare diseases. 2025年Q4的财务结果定于2026年1月20日公布。 Financial results for Q4 2025 are set for release on January 20, 2026. 其投资者关系网站提供了更多信息。 Additional information is available on its investor relations website.